Comparing Adagio Medical (ADGM) and Its Rivals

Adagio Medical (NASDAQ:ADGM) is one of 142 publicly-traded companies in the “MED INSTRUMENTS” industry, but how does it contrast to its competitors? We will compare Adagio Medical to related businesses based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, institutional ownership and dividends.

Institutional & Insider Ownership

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 54.1% of shares of all “MED INSTRUMENTS” companies are held by institutional investors. 5.2% of Adagio Medical shares are held by insiders. Comparatively, 14.2% of shares of all “MED INSTRUMENTS” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Adagio Medical and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-248.26%	-125.31%
Adagio Medical Competitors	-182.04%	-90.31%	-20.57%

Volatility & Risk

Adagio Medical has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500. Comparatively, Adagio Medical’s competitors have a beta of 1.89, meaning that their average stock price is 89% more volatile than the S&P 500.

Valuation and Earnings

This table compares Adagio Medical and its competitors gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Adagio Medical	$600,000.00	-$75.04 million	-1.75
Adagio Medical Competitors	$1.75 billion	$196.07 million	5.48

Adagio Medical’s competitors have higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Adagio Medical and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1	0	0	0	1.00
Adagio Medical Competitors	1175	3806	7143	267	2.52

As a group, “MED INSTRUMENTS” companies have a potential upside of 18.54%. Given Adagio Medical’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical has less favorable growth aspects than its competitors.

Summary

Adagio Medical competitors beat Adagio Medical on 12 of the 13 factors compared.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.